Why invest in AMS
We are a leading developer and manufacturer of advanced products for the global surgical and wound care markets. We can offer:
Share performance and key events over the last 10 years
We have an outstanding historical track record:
- Strong presence in US and EU markets
- Reinforced partnerships with large healthcare companies
- Investment in direct sales force in core markets
- Selective acquisitions successfully integrated in the Group
- Sales and EBITDA 5 year CAGR of 21% and 30% respectively
- Well positioned customer oriented product portfolio
- Constant investment in R&D
- Strong share price performance
…..and a clear strategy
- Continued expansion in the US and newer territories
- Move towards more value added partnerships
- Development of specialised sales teams to serve new segments
- Explore opportunities for synergistic acquisitions
- Leverage existing platform and seek further operational efficiencies
- Extend product range
- Attractive pipe-line of new products
- Clear mandate from investors to pursue growth
The Corporate Growth Strategy can be outlined as follows: